Share Tips

Sigma Pharmaceuticals (SIP) posted a FY12 net profit of $49.2 million

Sigma Pharmaceuticals Limited manufactures, wholesale and distributes prescription, over-the-counter and generic pharmaceutical products. The Company also owns a number of pharmacy banner brands in Australia. Small Cap Sigma Pharmaceuticals posted a FY12 net profit of $49.2 million, a massive turnaround from the $235.4 million loss in the prior corresponding year The rise in profit came

Australian Stock Report Ltd ACN 106 863 978 AFS License 301682 (ASR) is licensed as an Australian Financial Services License pursuant to section 9138 of the Corporations Act 2001 (Cth). Before acquiring or using any of Australian Stock Report's products, you should obtain & consider our Financial Services Guide. As of 30 June 2014, ASR no longer provides general advice on CFDs or CFD platforms.